Business
Charles River Enters Manufacturing Collaboration with Gazi University
WILMINGTON, Mass., January 21, 2026--Charles River Laboratories International, Inc. (NYSE: CRL) and Gazi University Faculty of Medicine, today announced a gene therapy contract development and manufacturing organization (CDMO) collaboration, providing plasmid DNA for AAV production and in vitro efficacy studies.
About this update from Charles River Laboratories International, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1245,"height":326,"url":"https://media.zenfs.com/en/business-wire.com/77e320da33c07f97f7972aba60fd1ed0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/lMfv2yHTwWq9l1Ejy6ropw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI1MTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/77e320da33c07f97f7972aba60fd1ed0","width":960,"height":251},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/q2pvhnZ853faAbIiGjU7IQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD02Mjg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/77e320da33c07f97f7972aba60fd1ed0","width":1200,"height":314}},"lazy":false},{"type":"text","content":"Cell and Gene Therapy CDMO to bolster rare disease research at Gazi University Faculty of Medicine","length":98,"tagName":"p","attribs":{}},{"type":"text","content":"WILMINGTON, Mass., January 21, 2026--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) and Gazi University Faculty of Medicine, today announced a gene therapy contract development and manufacturing organization (CDMO) collaboration, providing plasmid DNA for AAV production and in vitro efficacy studies.","length":330,"tagName":"p"},{"type":"text","content":""We are excited to build a strong collaboration with Gazi University," said Kerstin Dolph, Corporate Senior Vice President, Global Manufacturing, Charles River. "Leveraging cell and gene therapy CDMO expertise will enable the Faculty of Medicine to test and ultimately transform ground-breaking concepts into real-world therapies."","length":351,"tagName":"p"},{"type":"text","content":"Hyperphosphatemic tumoral calcinosis (HTC) is a rare inherited disorder causing high blood phosphate and painful, non-cancerous calcium phosphate deposits in soft tissues, especially around joints like hips, shoulders, and elbows, leading to pain, inflammation, and movement issues. It is caused by genetic defects in regulating phosphate, and Gazi University has identified GALNT3 as the responsible gene. Charles River will supply Gazi University with off-the-shelf research-grade AAV plasmids, offering a pre-manufactured and ready-to-use option for early-stage gene therapy programs. These plasmids are produced with animal component-free methods and are royalty-...
More updates from Charles River Laboratories International, Inc.